PharVision Advisers’s Ciena CIEN Stock Holding History

PharVision Advisers’s Portfolio CIEN Stock Details CIEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,044	Closed	-$244K	–	205
2025 Q4	$244K	Sell	1,044 -510	-33%	-$98.9K	0.12%	409
2025 Q3	$226K	Buy	+1,554	New	+$158K	0.13%	406

Other funds holding CIEN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PharVision Advisers's CIEN Position: Q1 2026 in Review

PharVision Advisers sold out of Ciena (CIEN) in Q1 2026, closing a stake of 1,044 shares — an estimated $244K sold.

PharVision Advisers first reported a position in CIEN in Q3 2025 and held it in 2 quarters. The position peaked at $244K in Q4 2025. 1,081 funds tracked by Wall St. Rank hold CIEN as of Q1 2026.

PharVision Advisers reported no remaining Ciena position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,044 Ciena shares in Q1 2026, an estimated $244K.
PharVision Advisers first reported a position in Ciena in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Ciena position peaked at $244K in Q4 2025.
1,081 funds tracked by Wall St. Rank held Ciena as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.